Skip to main content
OpenTrials
Enrolling by invitation

NCT Number: NCT07761273

Tricuspid Valve Reconstruction Using the Right Atrial Appendage

we use part of the cardiac chambre for replacement of destroyed valve on right side of the heart

Enrolling by invitation

Interested in participating?

Request Info

Key information

Conditions

Tricuspid Valve Disease

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Amr El Sayed Tawfek, Zagazig, Sharqia Province, Egypt

Loading trial locations.

About this study

Tricuspid Valve Reconstruction Using the Right Atrial Appendage by harvesting appropriate size then reconstruction as bileaflet valve after reinforcement of the annulus by pericardial band then the neovalve fixed to papillary muscles of the right ventricle by artificial chorda anchored by teflon pledgets

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all patient need tricuspid valve replacement

Exclusion criteria

  • patient refusal

Treatment and study plan

Tricuspid Valve Reconstruction

Procedure

Tricuspid Valve Reconstruction using right atrial appendage

tricuspid valve replacement

Procedure

tricuspid valve replacement using tissue valve

Primary outcomes

  1. Mortality

    Time frame: 30 day post operative

    perioperative and short-term mortality, with no major procedure-related surgical complication

  2. Morbidity

    Time frame: 30 day post operative

  3. measuring pressure gradient

    Time frame: 6 months postoperative

    Follow-up echocardiography by measuring pressure gradient across the neo valve

  4. Thromboembolic Risk checklist

    Time frame: 6 months postoperative

Interested in participating?

Enrolling by invitation

Interested in participating?

Request Info

Sponsors and collaborators

Lead sponsor

Zagazig University

Other Gov

Registry information

Important dates

Study start
2026
Primary completion
2026
Study completion
2027
First posted
Aug 12, 2026
Registry last updated
Aug 12, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.